Treatment of Acute Myeloid Leukemia With Venetoclax-Based Combinations in Argentina: A Real-World Study

被引:0
|
作者
Rivero Equiza, Tomas [1 ]
Cazap, Nicolas [1 ,2 ]
Garcia Altuve, Juan Ignacio [1 ]
Fornillo, Florencia [1 ,3 ]
Maymo, Daniela [4 ]
Riera, Leandro [1 ,3 ]
机构
[1] CEMIC, Buenos Aires, DF, Argentina
[2] Clin Olivos, Buenos Aires, DF, Argentina
[3] Clin AMEBPBA, Buenos Aires, DF, Argentina
[4] Hosp Posadas, Buenos Aires, DF, Argentina
来源
关键词
AML; venetoclax;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AML-592
引用
收藏
页码:S323 / S324
页数:2
相关论文
共 50 条
  • [1] Real-World Experience with Venetoclax-Based Regimens for the Treatment of Acute Myeloid Leukemia
    Ceparano, Giusy
    Sciume, Mariarita
    Fabris, Sonia
    Barozzi, Enrico
    Rampi, Nicolo
    De Roberto, Pasquale
    Baldini, Luca
    Fracchiolla, Nicola Stefano
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S298 - S298
  • [2] Building on Foundations: Venetoclax-Based Combinations in the Treatment of Acute Myeloid Leukemia
    Oyogoa, Emmanuella
    Traer, Elie
    Tyner, Jeffrey
    Lachowiez, Curtis
    CANCERS, 2023, 15 (14)
  • [3] Venetoclax-based combinations for the treatment of newly diagnosed acute myeloid leukemia
    Othman, Tamer A.
    Azenkot, Tali
    Moskoff, Benjamin N.
    Tenold, Matthew E.
    Jonas, Brian A.
    FUTURE ONCOLOGY, 2021, 17 (23) : 2989 - 3005
  • [4] Efficacy, Toxicity and Cost of Venetoclax-Based Combinations for the Treatment of Acute Myeloid Leukemia: Real-World Evidence from a Canadian Academic Center
    Bouchard, Philippe
    Brisebois-Boyer, Annie
    Beaudry, Anne
    Berthiaume, Jean-Francois
    Bambace, Nadia M.
    Bernard, Lea
    Hebert, Josee
    Bergeron, Julie
    BLOOD, 2021, 138
  • [5] Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study
    Zhao, Lei
    Yang, Jinjun
    Chen, Mengran
    Xiang, Xinrong
    Ma, Hongbing
    Niu, Ting
    Gong, Yuping
    Chen, Xinchuan
    Liu, Jiazhuo
    Wu, Yu
    ANNALS OF HEMATOLOGY, 2024, 103 (04) : 1197 - 1209
  • [6] Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study
    Lei Zhao
    Jinjun Yang
    Mengran Chen
    Xinrong Xiang
    Hongbing Ma
    Ting Niu
    Yuping Gong
    Xinchuan Chen
    Jiazhuo Liu
    Yu Wu
    Annals of Hematology, 2024, 103 : 1197 - 1209
  • [7] Real-world tolerability of venetoclax-based maintenance therapy with azole antifungal prophylaxis for acute myeloid leukemia in remission
    Nguyen, Phillip C.
    Donati, Vanessa
    Vassili, Catherine
    Grigg, Andrew P.
    Tiong, Ing S.
    LEUKEMIA RESEARCH, 2022, 116
  • [8] Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions
    Samra, Bachar
    Konopleva, Marina
    Isidori, Alessandro
    Daver, Naval
    DiNardo, Courtney
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [9] Molecular determinants of therapy response of venetoclax-based combinations in acute myeloid leukemia
    Makowka, Philipp
    Stolp, Verena
    Stoschek, Karoline
    Serve, Hubert
    BIOLOGICAL CHEMISTRY, 2021, 402 (12) : 1547 - 1564
  • [10] Real-world experience with venetoclax-based therapy for patients with myeloid sarcoma
    Jian, Xinyi
    Cha, Jie
    Lin, Zhijuan
    Xie, Siting
    Huang, Yueting
    Lin, Yun
    Zhao, Haijun
    Xu, Bing
    Luo, Yiming
    DISCOVER ONCOLOGY, 2024, 15 (01)